Info
🌱 來自:mobilization agent
motixafortide
- Hoy SM. Motixafortide: First Approval. Drugs. 2023;83(17):1635-1643. doi:https://doi.org/10.1007/s40265-023-01962-w
- Crees Z, Rettig MP, Asad Bashey, et al. Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor. Blood Advances. 2023;7(18):5210-5214. doi:https://doi.org/10.1182/bloodadvances.2023010407